121 related articles for article (PubMed ID: 28498881)
1. Can p40 (Polyclonal) Replace p63 (Clone 4A4) in the Cytologic Diagnosis of Pulmonary Non-Small Cell Carcinoma?
Alexander M; Chiaffarano J; Zhou F; Cangiarella J; Yee-Chang M; Simsir A
Am J Clin Pathol; 2017 Jun; 147(6):580-588. PubMed ID: 28498881
[TBL] [Abstract][Full Text] [Related]
2. Tissue-preserving antibody cocktails to differentiate primary squamous cell carcinoma, adenocarcinoma, and small cell carcinoma of lung.
Brown AF; Sirohi D; Fukuoka J; Cagle PT; Policarpio-Nicolas M; Tacha D; Jagirdar J
Arch Pathol Lab Med; 2013 Sep; 137(9):1274-81. PubMed ID: 23289761
[TBL] [Abstract][Full Text] [Related]
3. Differentiating Small Cell Carcinoma From Squamous Cell Carcinoma in Cytologic Specimens: A Head-to-Head Comparison of p40 and p63 Using Cell Block Immunocytochemistry.
Gailey MP; Bellizzi AM; Jensen CS
Appl Immunohistochem Mol Morphol; 2016 Jan; 24(1):11-5. PubMed ID: 25906121
[TBL] [Abstract][Full Text] [Related]
4. Napsin A/p40 antibody cocktail for subtyping non-small cell lung carcinoma on cytology and small biopsy specimens.
Nishino M; Hoang MP; Della Pelle P; Morales-Oyarvide V; Huynh TG; Mark EJ; Mino-Kenudson M
Cancer Cytopathol; 2016 Jul; 124(7):472-84. PubMed ID: 27412420
[TBL] [Abstract][Full Text] [Related]
5. p40 (ΔNp63) is superior to p63 for the diagnosis of pulmonary squamous cell carcinoma.
Bishop JA; Teruya-Feldstein J; Westra WH; Pelosi G; Travis WD; Rekhtman N
Mod Pathol; 2012 Mar; 25(3):405-15. PubMed ID: 22056955
[TBL] [Abstract][Full Text] [Related]
6. Usefulness of GATA3 and p40 immunostains in the diagnosis of metastatic urothelial carcinoma in cytology specimens.
Brandler TC; Aziz MS; Rosen LM; Bhuiya TA; Yaskiv O
Cancer Cytopathol; 2014 Jun; 122(6):468-73. PubMed ID: 24711443
[TBL] [Abstract][Full Text] [Related]
7. ΔNp63 (p40) distribution inside lung cancer: a driver biomarker approach to tumor characterization.
Pelosi G; Rossi G; Cavazza A; Righi L; Maisonneuve P; Barbareschi M; Graziano P; Pastorino U; Garassino M; de Braud F; Papotti M
Int J Surg Pathol; 2013 Jun; 21(3):229-39. PubMed ID: 23486764
[TBL] [Abstract][Full Text] [Related]
8. p40 (ΔNp63) is more specific than p63 and cytokeratin 5 in identifying squamous cell carcinoma of bronchopulmonary origin: a review and comparative analysis.
Vogt AP; Cohen C; Siddiqui MT
Diagn Cytopathol; 2014 May; 42(5):453-8. PubMed ID: 24166777
[TBL] [Abstract][Full Text] [Related]
9. Cytomorphology of sebaceous carcinoma with analysis of p40 antibody expression.
Jain D; Mathur SR; Sharma MC; Iyer VK
Diagn Cytopathol; 2015 Jun; 43(6):456-61. PubMed ID: 25611456
[TBL] [Abstract][Full Text] [Related]
10. Refining the diagnosis and EGFR status of non-small cell lung carcinoma in biopsy and cytologic material, using a panel of mucin staining, TTF-1, cytokeratin 5/6, and P63, and EGFR mutation analysis.
Nicholson AG; Gonzalez D; Shah P; Pynegar MJ; Deshmukh M; Rice A; Popat S
J Thorac Oncol; 2010 Apr; 5(4):436-41. PubMed ID: 20068475
[TBL] [Abstract][Full Text] [Related]
11. Utility of p63 and p40 in Distinguishing Polymorphous Adenocarcinoma and Adenoid Cystic Carcinoma.
Atiq A; Mushtaq S; Hassan U; Loya A; Hussain M; Akhter N
Asian Pac J Cancer Prev; 2019 Oct; 20(10):2917-2921. PubMed ID: 31653135
[TBL] [Abstract][Full Text] [Related]
12. A study of ΔNp63 expression in lung non-small cell carcinomas.
Nonaka D
Am J Surg Pathol; 2012 Jun; 36(6):895-9. PubMed ID: 22367298
[TBL] [Abstract][Full Text] [Related]
13. Utility and pattern of positivity of p40 in the diagnosis of squamous cell carcinoma of the lung by cytology: the first study on fine needle aspiration smears.
Jain D; Mathur SR; Guleria R; Iyer VK
Cytopathology; 2014 Oct; 25(5):330-5. PubMed ID: 24128123
[TBL] [Abstract][Full Text] [Related]
14. Variations of P40 and P63 Immunostains in Different Grades of Esophageal Squamous Cell Carcinoma: A Potential Diagnostic Pitfall.
Chi Z; Balani J; Gopal P; Peng L; Hammer S
Appl Immunohistochem Mol Morphol; 2021 Oct; 29(9):674-679. PubMed ID: 34061488
[TBL] [Abstract][Full Text] [Related]
15. An immunohistochemical analysis of a newly developed, mouse monoclonal p40 (BC28) antibody in lung, bladder, skin, breast, prostate, and head and neck cancers.
Tacha D; Bremer R; Haas T; Qi W
Arch Pathol Lab Med; 2014 Oct; 138(10):1358-64. PubMed ID: 24528495
[TBL] [Abstract][Full Text] [Related]
16. [Application of protein markers in combination with ThinPrep bronchial brush cytology in classification of lung cancer subtypes].
Yang Y; Pan QJ; Teng MF; Li ZL; Zhao LL; Han NJ; Gao YN; Cao J
Zhonghua Zhong Liu Za Zhi; 2008 Aug; 30(8):616-9. PubMed ID: 19102942
[TBL] [Abstract][Full Text] [Related]
17. Cytology applications of p63 and TTF-1 immunostaining in differential diagnosis of lung cancers.
Wu M; Szporn AH; Zhang D; Wasserman P; Gan L; Miller L; Burstein DE
Diagn Cytopathol; 2005 Oct; 33(4):223-7. PubMed ID: 16138374
[TBL] [Abstract][Full Text] [Related]
18. Role of thyroid transcription factor-1 and P63 immunocytochemistry in cytologic typing of non-small cell lung carcinomas.
Sinna EA; Ezzat N; Sherif GM
J Egypt Natl Canc Inst; 2013 Dec; 25(4):209-18. PubMed ID: 24207093
[TBL] [Abstract][Full Text] [Related]
19. The diagnostic utility of zinc E-box 1 (ZEB1) transcription factor for identification of pulmonary sarcomatoid carcinoma in cytologic and surgical specimens.
Viswanathan K; Siddiqui MT; Borczuk AC
J Am Soc Cytopathol; 2020; 9(1):55-61. PubMed ID: 31677963
[TBL] [Abstract][Full Text] [Related]
20. Squamous cell carcinoma in serous effusions: Avoiding pitfalls in this rare encounter.
LePhong C; Hubbard EW; Van Meter S; Nodit L
Diagn Cytopathol; 2017 Dec; 45(12):1095-1099. PubMed ID: 29024544
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
